Skip to main content
Premium Trial:

Request an Annual Quote

Biocrates: Nicolas Schauer, Moritz Seuster, Wulf Fischer-Knuppertz

Austria-based Biocrates announced that it has appointed Nicolas Schauer as co-CEO and CSO along with Moritz Seuster as co-CEO and CFO. Wulf Fischer-Knuppertz is resigning from the firm's executive board and will continue to serve as a consultant. Prior to joining Biocrates, Schauer sold his own metabolite profiling company in 2017. 

The Scan

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.

Machine Learning Improves Diagnostic Accuracy of Breast Cancer MRI, Study Shows

Combining machine learning with radiologists' interpretations further increased the diagnostic accuracy of MRIs for breast cancer, a Science Translational Medicine paper finds.

Genome Damage in Neurons Triggers Alzheimer's-Linked Inflammation

Neurons harboring increased DNA double-strand breaks activate microglia to lead to neuroinflammation like that seen in Alzheimer's disease, a new Science Advances study finds.

Long COVID-19 Susceptibility Clues Contained in Blood Plasma Proteome

A longitudinal study in eBioMedicine found weeks-long blood plasma proteome shifts after SARS-CoV-2 infection, along with proteomic signatures that appeared to coincide with long Covid risk.